Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc., extending the application of its PharmacyChain blockchain technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement, announced July 30, 2026, is designed to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. This expansion leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the amended terms, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies stated that the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
This move is significant as it positions Datavault AI at the intersection of blockchain, AI, and healthcare data management, addressing growing demand for secure, patient-centric data solutions. The global health and wellness market, valued in the trillions, presents a substantial opportunity for technologies that empower individuals to control and monetize their own health data. By integrating its data science and acoustic sciences technologies—including WiSA, ADIO, and Sumerian—into healthcare, Datavault AI aims to provide comprehensive solutions for data perception, valuation, and secure monetization.
Datavault AI’s platform serves multiple industries, including high-performance computing software licensing for sports, entertainment, biotech, fintech, real estate, and more. The Information Data Exchange enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. The company’s technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics, and marketing automation.
For more details, the full press release is available at https://ibn.fm/vBAxH. Additional information about Datavault AI can be found at https://dvlt.ai and in the company’s newsroom at https://ibn.fm/DVLT.
